Public Employees Retirement System of Ohio Cuts Stake in Doximity, Inc. (NASDAQ:DOCS)

Public Employees Retirement System of Ohio decreased its holdings in Doximity, Inc. (NASDAQ:DOCSFree Report) by 2.4% in the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 44,550 shares of the company’s stock after selling 1,110 shares during the period. Public Employees Retirement System of Ohio’s holdings in Doximity were worth $1,941,000 as of its most recent SEC filing.

Other institutional investors also recently made changes to their positions in the company. Farther Finance Advisors LLC raised its holdings in Doximity by 324.2% during the 3rd quarter. Farther Finance Advisors LLC now owns 789 shares of the company’s stock valued at $34,000 after buying an additional 603 shares during the last quarter. Morse Asset Management Inc bought a new stake in Doximity during the 3rd quarter valued at $46,000. Blue Trust Inc. raised its holdings in Doximity by 621.4% during the 2nd quarter. Blue Trust Inc. now owns 1,385 shares of the company’s stock valued at $37,000 after buying an additional 1,193 shares during the last quarter. GAMMA Investing LLC raised its holdings in Doximity by 40.1% during the 3rd quarter. GAMMA Investing LLC now owns 1,439 shares of the company’s stock valued at $63,000 after buying an additional 412 shares during the last quarter. Finally, Quarry LP raised its holdings in Doximity by 101.2% during the 2nd quarter. Quarry LP now owns 1,616 shares of the company’s stock valued at $45,000 after buying an additional 131,253 shares during the last quarter. Hedge funds and other institutional investors own 87.19% of the company’s stock.

Doximity Stock Down 1.0 %

Shares of NASDAQ DOCS opened at $52.19 on Thursday. The firm’s 50-day moving average price is $48.58 and its 200-day moving average price is $38.46. The company has a market cap of $9.74 billion, a PE ratio of 59.99, a PEG ratio of 4.16 and a beta of 1.40. Doximity, Inc. has a 52-week low of $22.96 and a 52-week high of $61.75.

Analysts Set New Price Targets

DOCS has been the subject of a number of recent analyst reports. Wells Fargo & Company upgraded shares of Doximity from an “underweight” rating to an “equal weight” rating and upped their price target for the company from $19.00 to $41.00 in a report on Friday, November 8th. The Goldman Sachs Group initiated coverage on shares of Doximity in a report on Friday, November 15th. They issued a “neutral” rating and a $58.00 price objective for the company. Morgan Stanley upgraded shares of Doximity from an “underweight” rating to an “equal weight” rating and upped their price objective for the stock from $33.00 to $53.00 in a report on Thursday, November 14th. Barclays upped their price objective on shares of Doximity from $52.00 to $75.00 and gave the stock an “overweight” rating in a report on Monday, November 11th. Finally, Baird R W upgraded shares of Doximity to a “strong-buy” rating in a report on Tuesday, September 17th. Twelve investment analysts have rated the stock with a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $52.44.

Read Our Latest Stock Report on DOCS

About Doximity

(Free Report)

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.

See Also

Want to see what other hedge funds are holding DOCS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Doximity, Inc. (NASDAQ:DOCSFree Report).

Institutional Ownership by Quarter for Doximity (NASDAQ:DOCS)

Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter.